HEPSA

Refine your search

Your search returned 51 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
2.
3.
Financing viral hepatitis: catalysing action for impact by Series: Lancet Gastroenterlology & HepatologyLondon Lancet 2023
Online resources:
Availability: Items available for loan: Library (1).
4.
Financing viral hepatitis : catalysing action for impact by Series: Gastroenterlology & Hepatology ; Vol. 8 (7)London Lancet 2023
Online resources:
Availability: Items available for loan: Library (1).
5.
Economic benefits of increased Hep C testing and treatment by Sydney National Drug & Alcohol Research Centre (NDARC) 2022
Online resources:
Availability: Items available for loan: Library (1).
6.
Universal screening for hepatitis B virus offers better health outcomes, cost savings by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021
Online resources:
Availability: Items available for loan: Library (1).
7.
Disease expenditure in Australia 2018-19 by Canberra Australian Institute of Health and Welfare 2021
Online resources:
Availability: Items available for loan: Library (1).
8.
9.
HCV elimination: importance of investment by Thorofare NJ Healio 2021
Online resources:
Availability: Items available for loan: Library (1).
10.
11.
Global hepatitis C elimination: an investment framework by Series: The Lancet Gastroenterology & Hepatology ; Vol. 5 No.10London The Lancet 2020
Online resources:
Availability: Items available for loan: Library (1).
12.
13.
Enhancing the hepatitis B care cascade in Australia : a cost‐effectiveness model by Melbourne Journal of Viral Hepatitis (via John Wiley and Sons) 2019
Online resources:
Availability: Items available for loan: Library (1).
14.
Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015 by Series: Australian Burden of Disease StudyCanberra Aust Institute of Health & Welfare 2019
Online resources:
Availability: Items available for loan: Library (1).
15.
Economic evaluation of HCV testing approaches in low and middle income countries by Series: BMC Infectious Diseases | ; 17London BioMed Central 2018
Online resources:
Availability: Items available for loan: Library (1)Call number: 0.4.1.
16.
Eliminating viral hepatitis: the investment case. Report of the WISH viral hepatitis forum 2018 by Dohar, Qatar World Innovation Summit for Health 2018
Online resources:
Availability: Items available for loan: Library (1)Call number: 0.4.1.
17.
Financial case for action on liver disease Escalating costs of alcohol misuse, obesity and viral hepatitis by London Foundation for Liver Research 2017
Online resources:
Availability: Items available for loan: Library (1)Call number: 0.4.1.
18.
19.
Australian methamphetamine user outcomes by Series: Statistical bulletin ; 03Canberra Austalian Institute of Criminology 2017
Online resources:
Availability: Items available for loan: Library (1)Call number: 0.4.
20.
Pages

Powered by

Koha

Provided by

Hepatitis SA

Hosted by

Catalyst

Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.